Junction

173 posts

Junction banner
Junction

Junction

@tryVital

A single API for seamless integration of wearables & lab services, empowering health platforms to scale faster.

Request A Demo 👉 Katılım Şubat 2021
43 Takip Edilen275 Takipçiler
Junction retweetledi
Tuomas Malinen
Tuomas Malinen@mtmalinen·
So, let me get this straight, @SecWar . You just sank an Iranian frigate, which was returning from an international naval exercise in India, near Sri Lanka. In other words, you attacked an unsuspecting "enemy ship" in international waters, thousands of nautical miles from the combat zone in the Middle East. You know, who conducted such cowardly attacks on unsuspecting naval targets before you? Nazi Germany.
English
5.7K
12.3K
54.4K
2.9M
Sheel Mohnot
Sheel Mohnot@pitdesi·
Great framing- If you think about Function & Superpower as testing businesses, they are bad - those are thin layers on top of Labcorp or Quest, and all margins will get competed away. But you shoud think about them as a "give away the diagnostic, monetize the downstream" business... Like Credit Karma giving you a free credit score to sell you credit cards or your optometrist doing a cheap vision check to sell you glasses. The opportunity is what you do with the results... If they manage the interventions as your AI medical coach guiding you through life changes, using the blood test as context, and you trust the system and your outcomes improve over time, there is plenty of room to build a business with real margins. IMO this is the goal, and Hims comes at it from another angle (having started on the prescriptions side already). I wouldn't be surprised to see Amazon enter this space too (given pillpack, one medical, etc).
Max Marchione@maxmarchione

Blood testing is a lousy business. Attractive story, lots of hype, but poor economics. Most companies in the space will fail. But there is a way to succeed if you chart the right path. Here's why: 1) Low barriers to entry. You can now stand up lab testing via APIs in weeks. Most consumer blood testing companies are simply pretty wrappers on Labcorp and Quest. They do not own IP. They compete on sales, branding, and UI while renting the core capability from someone else. That alone is not a durable business. 2. Diagnostics margins are thin and compressing. Commoditization plus lack of proprietary IP drives economics down to the labs. Labcorp and Quest capture the value. Many founders copy the blood-testing piece of Superpower, ignoring the fact that our operating assumption is that there is little long-term margin in blood testing for anyone other than the labs. 3. Even the incumbents are not safe. Machine learning is changing how we measure biology. Once we have large datasets and good models, you don’t need to run every test through a traditional lab. You can infer biomarkers from a face photo, a cheap at-home sensor, or small sample of blood. Theranos was wrong on many things, not the direction of travel. There are already companies running 1,000+ biomarkers off a single drop. Over time, this could threaten Labcorp and Quest as well. So what actually works if you want to build a valuable company in this space? 1. Assume blood tests are a commodity. Begin with the premise that a blood test is no different than an AWS compute unit. Necessary, but not where you make your money. Design your strategy, product, and unit economics with that as the baseline assumption. 2. Don't rely on blood tests alone to acquire customers Selling someone a blood test is harder than it looks. For most people, it is a “nice to have,” not an urgent need. Blood tests are vitamins not painkillers. 3. Build the business downstream of the test. The value is in what happens after the lab result arrives. The longitudinal relationship. The decisions, behaviors, and outcomes you drive for the member. The protocols, interventions, logistics, and software. The winners won’t be “the next Labcorp.” They’ll be the companies that actually change human health. That use labs as a launchpad for a far great mission – preventing disease and enhancing human capability. That's what matters.

English
13
1
143
35.9K
Junction retweetledi
Eren Bali
Eren Bali@erenbali·
Something I genuinely wonder: why do anti capitalists seem a lot more bothered with the incomes of CEOs than incomes of elite athletes, musicians, actors etc? My guess they can comprehend the uniqueness of the skills of Taylor Swift or LeBron James but they have no idea what makes an elite CEO.
Josh Hawley@HawleyMO

Amazon’s CEO makes at least $40.1 MILLION a year while the average Amazon worker makes less than $38k a year How is that pro-worker or pro-American? It’s time to put American workers FIRST

English
663
391
7.7K
985.8K
Christina Farr
Christina Farr@chrissyfarr·
Quote of the day from calls I’ve had: Health care could use AI. But what it could really use are APIs.
English
11
3
39
3.9K
Junction retweetledi
Saloni
Saloni@salonium·
New article by me! Cardiovascular disease mortality rates have declined by around three-quarters since 1950, but we rarely hear about it. I explore some of the reasons behind the decline.
Saloni tweet media
English
26
246
1K
218.7K
Junction
Junction@tryVital·
Happy holidays everyone from Team Vital 👋 Join us to decrease the cost to predict, diagnose and prevent chronic disease by two orders of magnitude. New roles just landed on our careers page. jobs.ashbyhq.com/tryvital
Junction tweet media
English
0
0
1
504
Junction
Junction@tryVital·
We're searching for a product minded, Senior Backend Engineer based in London. Are you someone who wants to help predict chronic diseases - faster, at less cost? Read more here: jobs.ashbyhq.com/tryvital/7b73a…
English
0
0
1
348
Junction
Junction@tryVital·
🏃🏼 Short on time? Summary below Who you are: experienced, detail orientated startup operator Salary: $165,000 - $215,000 depending on experience + share options Time zone: ET timezone - US East Coast
English
0
0
0
240
Tellescope
Tellescope@JoinTellescope·
Tellescope and @tryVital have partnered to help #digitalhealth companies enrich their virtual #patientexperience. With Vital, companies can place lab orders with LabCorp, Quest, a mobile phlebotomist, and at-home testing kits and share results with patients through Tellescope.
Tellescope tweet media
English
1
1
3
151
Junction
Junction@tryVital·
'Care organisations should focus on PROVIDER experience and NOT on PATIENT experience' Thanks @rikrenard for sharing your 2024 Health Predictions + Hot Takes 🔥
English
6
1
9
2.9K
Junction
Junction@tryVital·
From Fertility Clinics to Men's Health - we work with the fastest-growing digital health companies to help streamline access to granular health data from wearables and lab tests. Website: buff.ly/3t9YEKi Blog: buff.ly/3ZxXPXL
English
0
0
0
422
Junction
Junction@tryVital·
📊 Horizon AI: Leverage predictive analytics and research APIs powered by ML for personalized insights across labs and wearables data.
English
1
0
0
518
Junction
Junction@tryVital·
🔥 ANNOUNCING OUR NEW WEBSITE + NEW TESTING OPTIONS🔥 At Vital, we believe the future of healthcare will be at-home, data-driven and personalized to truly improve care outcomes ❤️‍🩹
English
1
3
7
3.1K
Junction
Junction@tryVital·
🧪 Lab Testing data across key biomarkers like HbA1, ALC, WBC AND ⌚️Wearables data across key biomarkers like blood glucose, activity, heart rate Check out the study below! 👇 buff.ly/44VAQXW
English
0
0
0
230
Junction
Junction@tryVital·
Why is this exciting? 🚨Early detection = less complications = timely interventions = reduced costs 🚨 At Vital we’re excited to work with leading Diabetes Care Management companies to help them access to:
English
1
0
0
243
Junction
Junction@tryVital·
Most people think fasting blood glucose identifies ALL diabetes cases But it’s not always true… Some diabetics may not show abnormalities in their normal fasting blood glucose Meaning you HAVE diabetes, you just don’t know it 😬
English
1
0
0
286